A comparison of the clinical impact of bleeding measured by two different classifications among patients with acute coronary syndromes

被引:282
作者
Rao, SV
O'Grady, K
Pieper, KS
Granger, CB
Newby, LKI
Mahaffey, KW
Moliterno, DJ
Lincof, AM
Armstrong, PW
Van de Werf, F
Califf, RM
Harrington, RA
机构
[1] Duke Clin Res Inst, Durham, NC 27715 USA
[2] Univ Kentucky, Lexington, KY USA
[3] Cleveland Clin Fdn, Cleveland, OH 44195 USA
[4] Univ Alberta, Edmonton, AB, Canada
[5] Univ Ziekenhuizen Leuven, Louvain, Belgium
关键词
D O I
10.1016/j.jacc.2005.09.060
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
OBJECTIVES The goal of this study was to determine the association between Thrombolysis In Myocardial Infarction (TTMI) and Global Use of Strategies to Open Occluded Coronary Arteries (GUSTO) bleeding and clinical outcomes. BACKGROUND There are limited data on the relative utilty of either scale at predicting clinical outcomes in patients with non-ST-segment elevation acute coronary syndromes (ACS). METHODS Pooled data from two randomized trials of patients with ACS (n = 15,454) were analyzed to determine the association between TIMI and GUSTO bleeding and 30-day and 6-nionth death/myocardial infarction (MI) using Cox proportional hazards modeling that included bleeding as a time-dependant covariate. RESULTS There was a stepwise increase in the adjusted hazard of 30-day death/MI with worsening GUSTO bleeding (hazard ratio [95% confidence interval], GUSTO mild 1.20 [1.05 to 1.37]; moderate 3.28 [2.88 to 3.73]; severe 5.57 [4.33 to 7.17]), and an increased risk with A three levels of TIMI bleeding (TIMI minimal 1.84 [1.63 to 2.08]; TIMI minor 1.64 [1.31 to 2.04]; major 1.45 [1.23 to 1.70]). When both bleeding scales were included in the same model, the risk with GUSTO bleeding persisted; however, the association between TIMI bleeding and outcome was no longer significant. CONCLUSIONS Both scales identify ACS patients with bleeding complications at risk for adverse outcomes. In a model that included both definitions, the risk with GUSTO bleeding persisted while the risk with TIMI bleeding did not. This suggests that bleeding assessed with clinical criteria is more important than that assessed by laboratory criteria in terms of outcomes. Future clinical trials should consider using a combination of the GUSTO bleeding scale and the need for transfusion to assess bleeding complications.
引用
收藏
页码:809 / 816
页数:8
相关论文
共 25 条
  • [1] Bazzino O, 1998, NEW ENGL J MED, V338, P1498
  • [2] Bazzino O, 1998, NEW ENGL J MED, V338, P1488
  • [3] Prospective comparison of hemorrhagic complications after treatment with enoxaparin versus unfractionated heparin for unstable angina pectoris or non-ST-segment elevation acute myocardial infarction
    Berkowitz, SD
    Stinnett, S
    Cohen, M
    Fromell, GJ
    Bigonzi, F
    [J]. AMERICAN JOURNAL OF CARDIOLOGY, 2001, 88 (11) : 1230 - 1234
  • [4] Predictors of outcome in patients with acute coronary syndromes without persistent ST-segment elevation results from an international trial of 9461 patients
    Boersma, E
    Pieper, KS
    Steyerberg, EW
    Wilcox, RG
    Chang, WC
    Lee, KL
    Akkerhuis, KM
    Harrington, RA
    Deckers, JW
    Armstrong, PW
    Lincoff, AM
    Califf, RM
    Topol, EJ
    Simoons, ML
    [J]. CIRCULATION, 2000, 101 (22) : 2557 - 2567
  • [5] USE OF A MONOCLONAL-ANTIBODY DIRECTED AGAINST THE PLATELET GLYCOPROTEIN IIB/IIIA RECEPTOR IN HIGH-RISK CORONARY ANGIOPLASTY
    CALIFF, RM
    SHADOFF, N
    VALETT, N
    BATES, E
    GALEANA, A
    KNOPF, W
    SHAFTEL, J
    BENDER, MJ
    AVERSANO, T
    RAQUENO, J
    GURBEL, P
    COWFER, J
    COHEN, M
    CROSS, P
    BITTL, J
    EDDINGS, K
    TAYLOR, M
    DEROSA, K
    HATTEL, L
    COOPER, L
    ESHELMAN, B
    FINTEL, D
    NIEMYSKI, P
    KLEIN, L
    KENNEDY, H
    THORNTON, T
    KEREIAKES, D
    MARTIN, L
    ANDERSON, L
    HIGBY, N
    ELLIS, S
    BREZINA, K
    GEORGE, B
    CHAPEKIS, A
    SMITH, D
    ANWAR, A
    GERBER, TL
    PRITCHARD, GL
    MYLER, R
    SHAW, R
    MURPHY, M
    WARD, K
    MADIGAN, NP
    BLANKENSHIP, J
    HALBERT, M
    FLANAGAN, C
    TANNENBAUM, M
    POLICH, M
    STEVENSON, C
    TCHENG, J
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1994, 330 (14) : 956 - 961
  • [6] Comparison of early invasive and conservative strategies in patients with unstable coronary syndromes treated with the glycoprotein IIb/IIIa inhibitor tirofiban.
    Cannon, CP
    Weintraub, WS
    Demopoulos, LA
    Vicari, R
    Frey, MJ
    Lakkis, N
    Neumann, FJ
    Robertson, DH
    DeLucca, PT
    DiBattiste, PM
    Gibson, CM
    Braunwald, E
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2001, 344 (25) : 1879 - 1887
  • [7] American College of Cardiology key data elements and definitions for measuring the clinical management and outcomes of patients with acute coronary syndromes - A report of the American College of Cardiology Task Force on Clinical Data Standards (Acute Coronary Syndromes Writing Committee)
    Cannon, CP
    Battler, A
    Brindis, RG
    Cox, JL
    Ellis, SG
    Every, NR
    Flaherty, JT
    Harrington, RA
    Krumholz, HM
    Simoons, ML
    Van de Werf, FJJ
    Weintraub, WS
    Mitchell, KR
    Morrisson, SL
    Brandis, RG
    Anderson, HV
    Cannom, DS
    Chitwood, WR
    Cigarroa, JE
    Collins-Nakai, RL
    Ellis, SG
    Gibbons, RJ
    Grover, FL
    Heidenreich, PA
    Khandheria, BK
    Knoebel, SB
    Krumholz, HL
    Malenka, DJ
    Mark, DB
    McKay, CR
    Passamani, ER
    Radford, MJ
    Riner, RN
    Schwartz, JB
    Shaw, RE
    Shemin, RJ
    Van Fossen, DB
    Verrier, ED
    Watkins, MW
    Phoubandith, DR
    Furnelli, T
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2001, 38 (07) : 2114 - 2130
  • [8] THROMBOLYSIS IN MYOCARDIAL-INFARCTION (TIMI) TRIAL, PHASE-I - A COMPARISON BETWEEN INTRAVENOUS TISSUE PLASMINOGEN-ACTIVATOR AND INTRAVENOUS STREPTOKINASE - CLINICAL FINDINGS THROUGH HOSPITAL DISCHARGE
    CHESEBRO, JH
    KNATTERUD, G
    ROBERTS, R
    BORER, J
    COHEN, LS
    DALEN, J
    DODGE, HT
    FRANCIS, CK
    HILLIS, D
    LUDBROOK, P
    MARKIS, JE
    MUELLER, H
    PASSAMANI, ER
    POWERS, ER
    RAO, AK
    ROBERTSON, T
    ROSS, A
    RYAN, TJ
    SOBEL, BE
    WILLERSON, J
    WILLIAMS, DO
    ZARET, BL
    BRAUNWALD, E
    [J]. CIRCULATION, 1987, 76 (01) : 142 - 154
  • [9] FAITHFULL NS, 1992, ADV EXP MED BIOL, V317, P55
  • [10] Ferguson JJ, 2004, JAMA-J AM MED ASSOC, V292, P45